Cardiomyocytes are terminally differentiated cells and thus do not have the ability to dilute damaged proteins and organelles by cell division. Thus, proteolytic and recycling systems within the cardiomyocyte are essential to maintain cardiac function. The major proteolytic systems in the cell are: the ubiquitin -proteasome system, autophagy, and calpain. The ubiquitin-proteasome system degrades specific proteins by labelling them with ubiquitin. Autophagy degrades cytosolic proteins and organelles; this is generally believed to be a non-specific type of degradation. Calpain is a Ca 2+ -sensitive cysteine protease that degrades intracellular substrates including cytoskeletal proteins, and participates in Ca 2+ -mediated intracellular processes. All three systems exist in the cardiomyocyte and play pivotal roles in maintaining cardiac function. However, there is still controversy regarding the role of each protein-degradation system in the heart. Our recent reports using cardiac-specific knockout mice have revealed the cardioprotective roles of autophagy and calpain in the development of heart failure. While these proteolytic systems exhibit distinct molecular mechanisms, they work cooperatively (one process can regulate another).
Introduction
Quality control of proteins and organelles in the cardiomyocyte is essential to maintain cardiac function and structure. A proper balance between protein synthesis and degradation is required to maintain the quantity and quality of intracellular proteins. Three major proteolytic systems have been identified within the cardiomyocyte: the protease system, autophagy, and the ubiquitin-proteasome system. These systems degrade proteins by distinct molecular mechanisms. Among proteases, calpain has been extensively studied, because an increase in intracellular Ca 2+ concentration is associated with various cardiovascular diseases. Calpain is a cytoplasmic cysteine protease that requires calcium ions for activity in Ca 2+ -mediated intracellular processes. 1, 2 Autophagy sequestrates proteins and organelles by using a double-membrane vacuole, the autophagosome, which is delivered to, and fuses with, a lysosome. The ubiquitin-proteasome system functions by labelling specific proteins with ubiquitin molecules, which are recognized and degraded by 26S proteasomes. Many intracellular short-lived proteins are selectively degraded by the ubiquitin-proteasome system.
Although the degradation of proteins in the cardiac sarcomere has been extensively studied, 3 -5 the precise mechanisms underlying cardiac proteolysis have been only recently identified. In this review, we describe the role of cardiomyocyte autophagy in physiological and pathological situations, the role of calpain in the pathogenesis of heart failure, and coordination of these two proteolytic systems.
Contribution of autophagy to cardiac structure and function maintenance
Autophagy is a mechanism that is highly conserved from yeast to mammals and plays a critical role in the clearance of cytoplasmic proteins and intracellular organelles. There are three different types of autophagy: macroautophagy, microautophagy, and chaperonemediated autophagy. 6 -8 These distinct autophagic systems differ in the mechanisms by which substrates are delivered to lysosomes. Microautophagy refers to a process of direct engulfment of cytosolic materials into the lysosome. In chaperone-mediated autophagy, proteins are translocated by heat shock protein 70 to the lysosome.
Macroautophagy is the most prominent and best-studied form of autophagy, and is the focus of this review. Macroautophagy will hereafter be referred to simply as 'autophagy'. Autophagy involves the sequestration of cytoplasmic material and organelles by an isolation membrane to form a double-membrane vacuole; enclosure of the isolation membrane results in the formation of an autophagosome. The autophagosome is then fused to a lysosome to form the autolysosome, in which the sequestered materials are degraded by enzymes of the lysosome. 9, 10 The products from the autolysosome are released to the cytoplasm and recycled for macromolecular synthesis and ATP generation. The principal role of autophagy is to supply nutrients for survival. 11 Nutrient starvation can induce autophagy in most cells of most tissues types. Autophagy has been thought to play a causative role in cell death. However, recent loss-of-function studies in mice indicate that autophagy occurs at low basal levels to perform homeostatic functions, and acts as an adaptive process in response to stress. 12 Autophagy is regulated by a core group of conserved autophagy-related (Atg) genes that were originally identified in yeast. 13, 14 Most have counterparts in higher eukaryotes including mammals, which has facilitated our understanding of mammalian autophagy. Some Atg genes, such as Atg5 and Atg7, are known to be essential for autophagosome formation.
Mice deficient in Atg5 in neural cells developed progressive deficits in motor function, with accumulation of cytoplasmic inclusion bodies. 15 Genetic deletion of autophagic genes such as Atg5 or Atg7 16 accelerated rather than inhibited cell death, which may highlight the predominant survival role of autophagy. Autophagic vacuoles are found in the cardiomyocytes of ischaemic hearts 17, 18 and cardiomyopathic hearts. 19, 20 Mice with a deficiency in lysosome-associated membrane protein-2 (a model of Danon disease) showed accumulation of autophagosomes and cardiomyopathy. 21, 22 Autophagy in the heart is up-regulated in response to stress such as ischaemia/reperfusion (I/R) injury, 23 heart failure, and nutrient starvation. Even in these diseased conditions, the morphology of autophagic vacuoles is indistinguishable from that in normal hearts at baseline. Autophagy is detected by electron microscopy (the standard method) as a double-membrane vesicle in the tissue samples. Electron microscopy is reliable but requires much skill and time. The detection of LC3 (microtubule-associated protein 1 light chain) by western blot or fluorescence studies, together with electron microscopy for autophagosome formation, are the mainstays for the detection of autophagy. However, an increase in autophagic flux should be established to conclude activation of autophagy. Thus, previous reports regarding the level of autophagy in the diseased hearts should be re-evaluated. Cardiomyocyte death plays an important role in the progression of heart failure. In human failing hearts, dying cardiomyocytes with characteristics of autophagy have been reported, 19, 24, 25 and autophagic cell death is thought to play a causative role in heart failure. Excessive autophagy has been hypothesized to cause autophagic cell death. However, a direct link between autophagy and cell death is yet to be demonstrated. Using electron microscopy, autophagic cell death can be distinguished from apoptosis and necrosis; it had been unclear whether autophagy is a sign of a compensatory mechanism or a cause of heart failure.
To elucidate the role of autophagy in physiological and pathological conditions, we analyzed Atg5-deficient mice. 26 The temporally controlled cardiac-specific deletion of Atg5 induced severe systolic dysfunction and left ventricle dilatation in 10-week-old mice, accompanied by disorganization of the sarcomere structure and misalignment and aggregation of mitochondria. Furthermore, absence of autophagy in the cardiomyocyte induced accumulation of polyubiquitinated proteins, increased endoplasmic reticulum stress, and apoptosis. Knockdown of Atg7 by an adenoviral vector expressing shRNA induced the morphological and biochemical features of in vitro cardiomyocyte hypertrophy. These results indicate that constitutive autophagy in the heart is essential to maintain cardiac structure and function. When Atg5 was ablated early in cardiogenesis in cardiac-specific method, the mice showed no cardiac phenotype until 10 weeks of age. They developed cardiac dysfunction and chamber dilatation one week after pressure overload or b-stimulation. In contrast, heterozygous disruption of Atg6 (the beclin 1 gene) inhibited pathological remodeling induced by pressure overload, indicating that activation of autophagy induced by hemodynamic stress is maladaptive. 27 These findings are opposite to those for the phenotypes observed in cardiac-specific Atg5-deficient mice. In wild-type mice subjected to pressure overload, beclin 1 was significantly upregulated. Furthermore, heterozygous disruption of beclin 1, which contains a pro-apoptotic BH3 domain, reduced autophagic activity in all organs. 28 Beclin 1 has been proposed to coordinate both apoptosis and autophagy through direct interaction with the anti-apoptotic family members Bcl-2 and/ or Bcl-X(L). 29 -31 These may contribute to the cardiac phenotypes in
The cardiac-specific Atg5-deficient mice began to die at six months. They exhibited significant cardiac dysfunction and chamber dilatation at 6-10 months of age. 32 Ultrastructural analysis revealed a disorganized sarcomere structure and collapsed mitochondria in Atg5-deficient hearts, with decreased mitochondrial respiratory functions and increased levels of reactive oxygen species. The age-associated reduction of autophagic activity has been previously reported. 33 -35 In the heart, the level of autophagy, as indicated by decreased levels of LC3-II (microtubule-associated protein 1 light chain 3-II), in hearts of 6-, 14-or 26-month-old mice was lower than that in young mice. 36 Increased autophagy might improve cellular resistance to stress by increasing the metabolic buffering capacity of cells. Furthermore, autophagy might enhance turnover of intracellular organelles and prevent the accumulation of damaged organelles, such as mitochondria. Damaged mitochondria can be a source of reactive oxygen species. Accumulation of damaged proteins and organelles is one of the reasons for age-associated malfunction of many biological processes. Autophagy-related genes are required for life-span extension in various long-lived mutant nematodes, and they promote survival in worms and flies exposed to prolonged starvation. 37 Autophagy mediates the essential and continuous turnover of intracellular proteins and organelles in the heart, to maintain global cardiac structure and function. Recently, there have been many reports concerning mitophagy (mitochondrion-specific autophagy), which suggest selective degradation of damaged mitochondria. Mitophagy has been reported to be mediated through Atg32 in yeast. 38, 39 The E3 ubiquitin ligase Parkin and the serine/threonine kinase PINK1 are key molecules that mediate mitophagy. 40, 41 The importance of mitophagy in the heart and for control of inflammation, 42 and a role for Parkin in cardioprotection mediated by ischaemic preconditioning 43 have been demonstrated. Induction of autophagy by Bnip3 is a protective response that involves recruitment of Parkin. 44 However, the precise mechanisms and regulation of mitophagy remain to be elucidated. In I/R injury, autophagy has been thought to play a protective role, possibly by reducing apoptosis, 17, 18 because autophagosomes have been observed after I/R injury. 45 In isolated cardiomyocytes, the inhibition of autophagy with N-3-methyladenine (3-MA) during anoxiareoxygenation caused an increase in the number of necrotic cells and a decrease in the live cell population. 46 Survival of cardiomyocytes subjected to glucose deprivation was decreased by 3-MA, suggesting that autophagy is protective against myocardial ischaemia in the cardiomyocyte. 47 Therefore, autophagy in the cardiomyocyte during anoxia-reoxygenation may have a protective effect. However, there are some reports that autophagy promotes cell death after I/R injury. Reduction by RNAi of beclin1 expression in cardiomyocytes reduced anoxia-reoxygenation-induced autophagy and enhanced cell survival. 48 These contradictory reports suggest that autophagy may have dual roles in I/R injury.
3. Calpain-dependent contribution to dystrophin cleavage and heart failure Calpain has been implicated in the pathogenesis of myocardial injury that follows I/R through myofibrillar protein degradation (Figure 1) . Increased intracellular Ca 2+ concentration induced by I/R activates calpain. 56 In myocytes and cardiomyocytes, both m-and m-calpain are expressed, and these degrade myofibrillar proteins such as troponin, tropomyosin, myosin, and titin. 57 -60 Their degradation has been reported to contribute to the development of ischaemic preconditioning and myocardial infarction. 61 -65 Dystrophin is also degraded by calpain, resulting in necrosis and apoptosis. 60, 66 Dystrophin-related protein complexes consisting of dystrophin, sarcoglycans, and dystroglycans provide a strong mechanical link between the intracellular cytoskeleton and the extracellular matrix. Therefore, degradation of dystrophin impairs sarcolemma integrity, leading to cardiac dysfunction and heart failure. 67 Genetic defects in dystrophinrelated proteins and dysfunction of the corresponding proteins commonly induce dilated cardiomyopathy, as is the case in Duchenne and Becker dystrophy. 68 Dystrophin is disrupted in the hearts of patients with end-stage heart failure, 69 thus indicating that disruption of myocardial dystrophin may be a common pathway in severe heart failure. Calpain-mediated disruption of dystrophin also plays an important role in chronic doxorubicin-induced cardiomyopathy. A marked reduction in dystrophin membrane localization and increased expression of calpain were observed in cardiomyocytes of doxorubicintreated rats. 70 TO-2 hamsters (an animal model of hereditary dilated cardiomyopathy) exhibited degradation of dystrophin and heart failure, which was attenuated by reduction of the activated form of calpain, mediated through ASK1 (apoptosis signal-regulating kinase 1) inhibition. 71 In rat hearts subjected to coronary artery ligation, the activity of calpain was increased. Therapeutic drugs such as angiotensin converting enzyme inhibitor (ACE-I) and angiotension II receptor blockers (ARB) reversed calpain activity, attenuated changes in dystrophin, and improved cardiac function. 72 Chronic b-adrenergic stimulation induced calpain activation and cardiac injury in ovariectomized female rats. 73 These results suggest that specific inhibition of calpain might be a therapeutic strategy for slowing the progression of heart failure, mediated through the degradation of dystrophin. However, reduced activity of myocardial calpain by overexpression of calpastatin, an endogenous inhibitor of calpain, resulted in progressive dilated cardiomyopathy. 74 The previous reports relied on chemical inhibitors that lacked complete specificity for calpain, or on overexpression of calpain or calpastatin. Therefore, experimental study using specific gene targeting is required.
The protective function of calpain in the heart
Disruption of calpain 4 abolishes the expression and activity of both m-and m-calpain. Homozygous disruption of calpain 4 results in embryonic lethality, with defects in the cardiovascular system and erythropoiesis. 75 -77 Because calpain-2-deficient mice, but not calpain-1-defecient mice, showed the embryonic-lethal phenotype, calpain 2 Figure 1 Dual role of calpain in the heart. External stress induces an increase in intracellular Ca 2+ concentration, leading to the activation of calpain. While calpain degrades contractile proteins and thus has a detrimental role, it is involved in membrane repair and protects the heart from membrane damage.
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had been predicted to be involved in vascular development. However, a recent study reported that the conditional knockout mice in which calpain 2 was expressed in placenta but not in fetus survived to adulthood. 78 This observation clearly indicates that m-calpain has a vital role. However, this molecule is unlikely to be associated significantly with cardiovascular development in the fetus, but, rather, is essential for placental integrity, because several reports have indicated that abnormalities in placental development cause defects in the embryonic cardiovascular system. Recently, we have reported the cardio-protective function of calpain using cardiac-specific calpain-4-deficient mice. 32 Cardiac-specific deletion of calpain 4 resulted in decreased levels of both m-and m-calpain and showed no cardiac phenotype under baseline conditions. Thus, ubiquitous calpain in cardiomyocytes is not essential for cardiac development in mice. However, disruption of calpain 4 caused left ventricle dilatation, contractile dysfunction, and heart failure one week after pressure overload by means of transverse aortic constriction. 32 Isoproterenol infusion for two weeks also induced left ventricular chamber dilatation and cardiac dysfunction in calpain 4 2/2 mice.
These results indicate a protective role for calpain in response to external stress, such as pressure overload or b-adrenergic stimulation.
Calpain exists in the cytosol in an inactive form, translocates to membranes, and is activated at the membrane in response to an increase in calcium concentration. 2, 79, 80 Pressure-overloaded calpain 4 2/2 mice showed Evans blue dye uptake, which indicates structural instability of the sarcolemma. An in situ membrane-repair assay demonstrated impaired membrane repair in calpain 4 2/2 cardiomyocytes. The data from this study were the first to identify the in vivo role of calpain in response to stress using a loss-of-function method. Proteolytic activation of calpain at the disrupted site of a membrane was evident at the earliest time point. Calpain activity may be required for cytoskeletal remodeling after membrane disruption (Figure 2) . 54 The exact role of calpain in the membrane repair process has not yet been elucidated. Further examinations should be performed to conclude which of calpain, m-, and/or m-calpain, is essential for 3mem-brane repair in the cardiomyocyte.
A link between the ubiquitinproteasome system and autophagy
The ubiquitin-proteasome and autophagy-lysosome systems are thought to have distinct substrates for degradation. It has been reported that inhibition of ubiquitin-proteasome system leads to an increase in autophagosome formation, and that suppression of autophagy leads in turn to an increase in ubiquitinated proteins. 15, 16, 81 This is largely due to p62/SQSTM1 accumulation after autophagy inhibition. In cardiac-specific Atg5-deficient mice, ubiquitinated protein also increased in the heart, 26 although the activity of proteasomes was increased. Pressure overload promotes accumulation of ubiquitinated protein aggregates in the heart, which is one of the triggers of autophagy. 82 This indicates that ubiquitinated protein aggregates in the heart, induced by haemodynamic stress, can also be substrates of autophagy. In in vitro experiments, aggregation of polyubiquitinated proteins was also sufficient to induce cardiomyocyte autophagy.
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The ubiquitin-binding protein p62 regulates the formation of protein aggregates and is removed by autophagy. NBR1 is also recruited to ubiquitin-positive protein aggregates and degraded by autophagy. NBR1 and p62 can act as receptors for selective autophagosomal degradation of ubiquitinated targets. These findings suggest a link between the ubiquitin-proteasome system and autophagy.
Crosstalk between autophagy and the calpain system in heart disease
In the regulation of autophagy induced by starvation, the precise molecular mechanism is not yet fully elucidated. Using high-throughput screening, seven drugs were identified that could induce autophagy without inducing cell death. 86 Interestingly, most of the seven compounds had activity in inhibiting intracellular Ca 2+ elevation. 87 -89 Previous studies have suggested a possible involvement of intracellular Ca 2+ in regulating autophagy, and that elevation of cytosolic Ca Proteolysis in hearts inhibits autophagy. 90 In contrast, normal physiological concentrations of cytosolic Ca 2+ may inhibit autophagy in an mTOR-independent manner. 90 These results suggest that calpain, as a Ca 2+ -dependent protease, may have a role in the regulation of autophagy. When using siRNA gene silencing, inhibition of calpain was sufficient to induce autophagy in living cells under nutrient-rich conditions. Reducing intracellular Ca 2+ prevented cleavage of Atg5, which led to an increase in the levels of full-length Atg5 and Atg12-Atg5 conjugate.
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Atg5 was reported to be sufficient to initiate the formation of autophagosomes. 92 Atg12 -Atg5 conjugate also enhances the formation of autophagosome by promoting the transfer of Atg8 to the substrate, phosphatidylethanolamine. 93 Therefore, calpain plays an important role in controlling the levels of autophagy by decreasing the levels of a key signalling molecule, the Atg12-Atg5 conjugate. Increasing sphingosine-1-phosphate (S1P) by deletion of the ER-resident S1P-degrading enzyme, S1P phosphohydrolase 1 (SPP1), induced protective autophagy. 94 Ablation of SPP1 led to doxorubicin-induced calpain-mediated cleavage of Atg5. 95 The resulting amino-terminal cleavage product translocated from the cytosol to mitochondria, associated with the anti-apoptotic molecule Bcl-xL, and triggered cytochrome c release and caspase activation. 96 Calpain-mediated cleavage of beclin-1 was also reported in vitro in an assay with recombinant beclin-1, 97 in cultured hepatocytes exposed to anoxia/reoxygenation, 98, 99 and in a retinal ischaemic injury model in vivo.
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Taken together, activated calpain not only inhibits autophagy through degradation of Atg5 and beclin-1, but also induces apoptotic cell death. However, cooperation of calpain and autophagy in the heart remains unproven.
Link between the ubiquitinproteasome system and calpain
The ubiquitin-proteasome and calpain systems are thought to have distinct substrates for degradation, because their recognition of substrates is quite different. In agreement with this, we did not observe the changes in the level of ubiquitination in calpain 4 2/2 hearts, as
shown by western blot analysis of heart extracts. A recent report indicated regulation of the ubiquitin-proteasome system by calpain. 74 Forced expression of m-calpain, but not of m-calpain, induced a significant increase in protein ubiquitination, both in isolated cardiomyocytes and in whole hearts. Inhibition of calpain activity by forced expression of calpastatin diminished ubiquitination of some specific myocardial proteins. These results indicate that the m-calpain function is upstream of ubiquitination and proteasomal degradation, for a subset of myocardial proteins.
Concluding remarks
Proteolysis mediated through the ubiquitin-proteasome system, autophagy, and the calpain system occurs in the cardiomyocyte. Under some circumstances, proteolysis is detrimental and induces cardiac dysfunction or cell death. However, degradation of damaged proteins and organelles by autophagy is protective in the heart, both under physiological and pathological conditions. The physiological function of calpain in the heart is still controversial: it has a detrimental effect on the degradation of sarcomeric proteins, but a protective effect through promotion of membrane repair. The roles of autophagy and calpain depend on the type of diseases, such as heart failure and IR injury. There have not been any estimates of the comparative frequency or magnitude of autophagy or calpain activation in heart failure or acute ischaemia. There is accumulating evidence that proteasomal and autophagic degradation work cooperatively to control protein quality. Figure 3 Schematic illustration of relationship between autophagy, the ubiquitin -proteasome system, and calpain in the pathogenesis of heart failure.
